Navigation Links
Gel assists head and neck cancer

According to researchers from Northwestern Medical School, an injectable gel may be useful in treating cancers of the head and neck. Head and neck squamous cell carcinoma affects about 20,000 Americans each year.// Given intravenously, the drug cisplatin has been shown to be an effective therapy for head and neck cancers, but because it affects the entire body when given through an IV, it can lead to serious side effects. Researchers studied 120 patients who were previously treated for their cancer.

Nearly 80 percent of the patients had been treated with more than one therapy including surgery, chemotherapy and radiotherapy. Some patients received a new treatment that combines cisplatin and epinephrine in a gel, which is injected directly into the tumor. Other patients received injections of a placebo gel. Tumors were injected up to six times per week over eight weeks.

Tumors responded in nearly 35 percent of the patients who received the cisplatin/epinephrine gel while 20 percent had complete responses. There was only a 5 percent response for those who received the placebo gel. Treatment goals for patients included pain control, wound care, symptom relief and better physical appearance. Patients who received the cisplatin/epinephrine gel met more of their treatment goals than the control group.

Authors of the study write, "Cisplatin/epinephrine injectable gel reduces tumor burden, ameliorates tumor symptoms, and provides a new therapeutic option for treating patients with squamous cell carcinoma of the head and neck."


'"/>




Page: 1

Related medicine news :

1. Arginine food bar assists people with angina
2. Laser technique assists beard problem
3. New drug assists patients suffering premature ejaculation
4. Vitamin B12 can help in detecting cancers
5. Want skin cancer? Please have a cigarette
6. New hope for cancer victims – will vaccine cure the deadly bug
7. Clintons new problem - Is the outgoing American president suffering from skin cancer?
8. Are cancer patients being taken for a ride?
9. Breast cancer treatment to be determined by gene test
10. Ductal lavage may detect early breast cancer
11. Beware of the oral patch! It could be cancer!!!

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gel assists head and neck cancer

(Date:11/21/2009)... New Haven Dental Group merges their practice ... CT. , (PRWEB) November 2...f partners Dr. David Gibson, Dr. Dean Cloutier, Dr... merged their growing practice with that of esteem...ickman decided he wanted to retire from dentistry ...
(Date:11/20/2009)...NGTON, Nov. 20 The Unit... Senate to make essential changes its health refor...ortion funding and conscience protection on aborti...nd include strong provisions for adequate affordab...care bill an "enormous disappointment" that create...
(Date:11/20/2009)...IS, Nov. 20 Centene Co...ill present at the Bank of America Merrill Lynch 2...09, at the Crowne Plaza Hotel Times Square in New ...ecember 2nd at 8:30 a.m. Eastern Time. Investors a...io webcast of Centene,s presentation at: http://w...
(Date:11/20/2009)...hed online November 20 in the Journal of the Nati...ears and hopes that often appear in news coverage ...e for both the media and journals to help alleviat...nd Steven Woloshin, M.D., M.S., of Center for Medi...Health Policy and Clinical Practice in New Hampshi...
(Date:11/20/2009)... short as 34 weeks, potentially adding to preemie ...ov. 20 (HealthDay News) -- Recent reports show tha...b in the United States. Now, a new study suggests...t constitutes a full-term birth in the first place...n the study considered a baby born at 34 to 36 wee...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4
...f patients who undergo male to female sex-change s...t that complications are common, according to a st... the urology journal BJU International. , A rese...atients who had undergone surgery and 70 who took ...
...lif., Sept. 20 Cardiva Medical, Inc.,a privately ...Augustine,Lien, Chairman and CEO, will present at ...sday, September 25th in New York City. Notably, th...learance. This new product builds on the success o...
... 20 The American Red Cross,and American Heart Ass...n,that would designate the first week of June as "...utomated External Defibrillator (AED) Week." The,b...ty of CPR and AED training and use to reduce death...
...utive and Current Banfield President Succeeds Scot...PORTLAND, Ore., Sept. 19 Effective September 19, ... Officer of Banfield, The Pet,Hospital(R), succeed...,President, Chief Operating Officer and Acting CEO...
... Leader of the Global Breast Cancer Movement, Rece... DALLAS, Sept. 19 Ambassador Nancy G. Brinker, fo...largest breast cancer,organization, and recently a...bin/prnh/20070122/NYM084LOGO ) Each year, Forbes ...
...., Sept. 19 Neurobiological,Technologies, Inc. an...e,fiscal year ended June 30, 2007, included in the...tember 13, 2007, contain a going concern,qualifica...short term investments of approximately $8.9 milli...
Other Medicine News:Health News:Most patients who have male-to-female sex-change surgery are happy, despite complications 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:National CPR/AED Awareness Week Introduced in Congress 2Health News:National CPR/AED Awareness Week Introduced in Congress 3Health News:Largest Privately-Owned Veterinary Practice in the World, Banfield, the Pet Hospital(R), Appoints New Chief Executive Officer 2Health News:Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer 2Health News:Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer 3Health News:Neurobiological Technologies Reports Going Concern Qualification 2
(Date:11/20/2009)... , , NATICK, Mass. and LONDON, Nov. 20 /...tion (NYSE: BSX ) today announced that it has re...g Administration (FDA) and CE Mark approval to mar...ent for the treatment of malignant esophageal stri... with resectable or non-resectable esophageal canc...
(Date:11/20/2009)... , , FRANKLIN LAKES, N.J., Nov. 20 /PRNews...ny) (NYSE: BDX ) today announced the completion ..., Michigan-based company that develops and manufac...latforms. ,, In May 2009, BD and HandyLab annou...commercialize molecular assays on the HandyLab Jag...
(Date:11/19/2009)... , , BIRMINGHAM, Ala., Nov. 19 /PRNewswi...asdaq: BCRX ) today announced the pricing of a pu...ock at $9.75 per share, resulting in gross proceed...offered by BioCryst pursuant to an effective shelf...Securities and Exchange Commission. BioCryst has ...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Learning Takes Place When You Get Things Right 53240 1Learning Takes Place When You Get Things Right 53240 2The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 1The First SamarionSolution Installed in Lake Charles Alzheimers Facility 53237 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 1Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 2Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 3Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk 4797 4
...linically Meaningful Primary Endpoint for Clinical...World Muscle Society,Congress -, SOUTH PLAINFIELD...ay announced promising findings in patients with D... 13th International World Muscle Society,(WMS) Con...ng the utility,of the 6-minute walk test (6MWT) as...
.... 29 Obese school-age,kids and teens can lose wei...pate in medium- to high-intensity behavioral manag...today by HHS, Agency for Healthcare,Research and Q...y behavioral management,programs studied met for m...r 6 months to 12 months. Effective programs includ...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Behavioral Modification Programs Help Obese Children Manage Their Weight 2Behavioral Modification Programs Help Obese Children Manage Their Weight 3
Codmans Micro Osseous Dissection Curette
Karlin XL Magnum Cup Curette
Caspar
Kerpel
Medicine Products: